Drug reference
baricitinib
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Musculoskeletal (TNF-alpha Inhibitors)
Mechanism of action
Janus kinases (JAKs) pathways inhibitor; JAK consists of a group of intracellular tyrosine kinases that transmit signals from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoieses and immune cell function.
Common side effects
- Nausea
- Acne
- Increased ALT/AST
- Platelet elevations
- Upper respiratory tract infections
Related conditions
Frequently asked questions
What drug class is baricitinib?
baricitinib belongs to: Musculoskeletal.
How does baricitinib work?
Janus kinases (JAKs) pathways inhibitor; JAK consists of a group of intracellular tyrosine kinases that transmit signals from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoieses and immune cell function.
What are the common side effects of baricitinib?
Nausea, Acne, Increased ALT/AST, Platelet elevations, Upper respiratory tract infections
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.